BioMarin Pharmaceutical Inc. (BM8.DE)
EUR 63.52
(0.92%)
EUR 63.52
(0.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.41 Billion | 2.09 Billion | 1.84 Billion | 1.86 Billion | 1.7 Billion | 1.49 Billion |
| Cost of Revenue | 514.85 Million | 483.66 Million | 470.51 Million | 524.27 Million | 359.46 Million | 315.26 Million |
| Gross Profit | 1.9 Billion | 1.61 Billion | 1.37 Billion | 1.33 Billion | 1.34 Billion | 1.17 Billion |
| Operating Expenses | 1.74 Billion | 1.57 Billion | 1.45 Billion | 1.43 Billion | 1.47 Billion | 1.34 Billion |
| Selling, General and Administrative Expenses | 937.3 Million | 854 Million | 759.37 Million | 737.66 Million | 680.92 Million | 604.35 Million |
| Research and Development Expenses | 746.77 Million | 649.6 Million | 628.79 Million | 628.11 Million | 715 Million | 696.32 Million |
| Other Expenses | -10.53 Million | -2.05 Million | 11.84 Million | 7.14 Million | 6.94 Million | 2.2 Million |
| Cost and Expenses | 2.26 Billion | 2.05 Billion | 1.92 Billion | 1.95 Billion | 1.82 Billion | 1.66 Billion |
| Operating Income | 158.09 Million | 149.56 Million | -82.34 Million | -36.76 Million | -100.45 Million | -123.52 Million |
| Interest Expense | 16.74 Million | 15.97 Million | 15.33 Million | 29.3 Million | 23.46 Million | 43.66 Million |
| Income Tax Expense | 20.91 Million | 8.01 Million | -11.27 Million | -901.42 Million | -70.96 Million | -65.49 Million |
| Earnings before Tax | 188.56 Million | 149.57 Million | -75.35 Million | -42.32 Million | -94.81 Million | -142.7 Million |
| Net Income | 167.64 Million | 141.56 Million | -64.08 Million | 854.02 Million | -23.84 Million | -77.21 Million |
| Earnings Per Share Basic | 0.89 | 0.76 | -0.35 | 4.72 | -0.13 | -0.44 |
| Earnings Per Share Diluted | 0.87 | 0.75 | -0.35 | 4.50 | -0.13 | -0.44 |
| Weighted Average Shares Outstanding | 192.69 Million | 185.26 Million | 182.85 Million | 191.67 Million | 179.03 Million | 177.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 191.59 Million | 188.96 Million | 182.85 Million | 191.67 Million | 179.03 Million | 177.26 Million |
| Gross Margin | 0.79 | 0.77 | 0.75 | 0.72 | 0.79 | 0.79 |
| EBIT Margin | 0.13 | 0.08 | 0.03 | -0.00 | -0.01 | -0.07 |
| Profit Margin | 0.07 | 0.07 | -0.03 | 0.46 | -0.01 | -0.05 |
| EBITDA | 276.48 Million | 163.32 Million | 33.72 Million | 35.33 Million | -22.24 Million | -100.25 Million |
| Earnings Before Tax Margin | 0.07 | 0.07 | -0.04 | -0.02 | -0.06 | -0.08 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 648.83 Million | 2.41 Billion | 646.2 Million | 581.32 Million | 595.27 Million | 596.41 Million |
| Cost of Revenue | 125.18 Million | 514.85 Million | 135.47 Million | 124.74 Million | 128.08 Million | 126.54 Million |
| Gross Profit | 523.65 Million | 1.9 Billion | 510.72 Million | 456.58 Million | 467.19 Million | 469.86 Million |
| Operating Expenses | 445.19 Million | 1.74 Billion | 496.45 Million | 431.01 Million | 408.32 Million | 410.51 Million |
| Selling, General and Administrative Expenses | 225.9 Million | - | 275 Million | 224 Million | 215.33 Million | 223 Million |
| Research and Development Expenses | 204.98 Million | - | 206.25 Million | 191.31 Million | 177.36 Million | 171.84 Million |
| Other Expenses | 1.26 Million | -10.53 Million | -6.83 Million | 4.04 Million | 3.08 Million | -10.83 Million |
| Cost and Expenses | 570.37 Million | 2.26 Billion | 631.92 Million | 555.75 Million | 536.4 Million | 537.06 Million |
| Operating Income | 88.46 Million | 158.09 Million | 14.21 Million | 25.66 Million | 58.87 Million | 59.34 Million |
| Interest Expense | 3.54 Million | 16.74 Million | 5.5 Million | 3.77 Million | 3.75 Million | 3.7 Million |
| Income Tax Expense | 16.88 Million | 20.91 Million | -1.04 Million | 1.29 Million | 14.77 Million | 5.9 Million |
| Earnings before Tax | 105.54 Million | 188.56 Million | 19.32 Million | 41.66 Million | 70.81 Million | 56.75 Million |
| Net Income | 88.66 Million | 167.64 Million | 20.37 Million | 40.37 Million | 56.04 Million | 50.85 Million |
| Earnings Per Share Basic | 0.47 | - | 0.11 | 0.21 | 0.30 | 0.27 |
| Earnings Per Share Diluted | 0.46 | - | 0.09 | 0.21 | 0.29 | 0.27 |
| Weighted Average Shares Outstanding | 193.22 Million | 192.69 Million | 235.35 Million | 188.21 Million | 187.94 Million | 186.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 199.26 Million | 191.59 Million | 191.83 Million | 191.17 Million | 194.99 Million | 194.36 Million |
| Gross Margin | 0.81 | 0.79 | 0.79 | 0.79 | 0.78 | 0.79 |
| EBIT Margin | 0.19 | - | 0.08 | 0.12 | 0.17 | 0.15 |
| Profit Margin | 0.14 | 0.07 | 0.03 | 0.07 | 0.09 | 0.09 |
| EBITDA | 126.44 Million | - | 51.69 Million | 71.13 Million | 99.98 Million | 86.88 Million |
| Earnings Before Tax Margin | 0.14 | 0.07 | 0.02 | 0.04 | 0.10 | 0.10 |
5994
4707
KBNT
SBER
CSLMU
TLX